Invention Grant
- Patent Title: Application of oncolytic viruses as immunostimulants for treatment of tumors and/or cancers
-
Application No.: US16478727Application Date: 2018-01-24
-
Publication No.: US11357804B2Publication Date: 2022-06-14
- Inventor: Ronghua Zhao , Yanjun Zheng , Fang Hu
- Applicant: HANGZHOU CONVERD CO., LTD.
- Applicant Address: CN Hangzhou
- Assignee: HANGZHOU CONVERD CO., LTD.
- Current Assignee: HANGZHOU CONVERD CO., LTD.
- Current Assignee Address: CN Hangzhou
- Agency: Ipsilon USA, LLP
- Priority: CN201710056371.5 20170125
- International Application: PCT/CN2018/073954 WO 20180124
- International Announcement: WO2018/137643 WO 20180802
- Main IPC: A61K35/761
- IPC: A61K35/761 ; A61P37/02 ; A61P35/00 ; C12N7/00
Abstract:
Provided is the use of selectively replicating oncolytic viruses in the preparation of immunostimulants for treatment of tumors and/or cancers, wherein the oncolytic viruses do not carry exogenous immunoregulatory genes.
Information query
